Celgene Corp. | Key People and Executives
Mark J. Alles
Chairman, President, CEO & COO
Patricia A. Hemingway Hall
Director
Julia A. Haller
Independent Director
Michael W. Bonney
Independent Director
Michael A. Friedman
Independent Director
James J. Loughlin
Independent Director
Ernest Mario
Independent Director
Richard W. Barker
Independent Director
Michael D. Casey
Lead Independent Director
Carrie Smith Cox
Independent Director
Mark J. Alles
Chairman, President, CEO & COO
David V. Elkins
Chief Financial Officer & Executive Vice President
Jay T. Backstrom
Chief Medical Officer
Rupert J. Vessey
President-Research & Early Development
Joseph S. Camardo
Senior Vice President-Global Medical Affairs
Peter N. Kellogg
Chief Corporate Strategy Officer & Executive VP
Joanne Beck
EVP-Pharmaceutical Development & Operations
Anjan G. Thakurta
Executive Director-Translational Development
Nadim Ahmed
President-Hematology & Oncology
Ho Sung Cho
Vice President-Biotherapeutics
Kristen M. Hege
Corporate VP-Translational Development
Terrie Curran
President-Global Inflammation & Immunology
Catherine B. Elflein
Senior Director-Risk Management
Richard H. Bagger
SVP-Corporate Affairs & Strategic Market Access
Thomas Perone
Vice President-Legal
Patricia A. Hemingway Hall
Director
Stacey Minton
Senior Director-Public Relations
Brian P. Gill
VP-Corporate Affairs & Communications
Patrick E. Flanigan
Vice President-Investor Relations
Carol Thompson
Senior Director-Human Resources
Jonathan Prim Biller
Executive Vice President & General Counsel
Jennifer Dudinak
Senior Vice President-Global Regulatory Affairs
Julia A. Haller
Independent Director
Michael W. Bonney
Independent Director
Michael A. Friedman
Independent Director
James J. Loughlin
Independent Director
Ernest Mario
Independent Director
Richard W. Barker
Independent Director
Michael D. Casey
Lead Independent Director
Carrie Smith Cox
Independent Director
| Address |
86 Morris Avenue
Summit New Jersey 07901
United States
|
|
Employees
|
- |
| Website |
http://www.celgene.com |
| Updated |
07/08/2019 |
| Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its targeting areas include intracellular signaling pathways, protein homeostasis and epigenetics in cancer and immune cells, immunomodulation in cancer and autoimmune diseases and therapeutic application of cell therapies. The company's products include Revlimid, Vidaza, Thalomid, Pomalyst/Imnovid, Abraxane, and Istodax. |
